3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma
7
Lymphoma, Follicular
6
Leukemia, Biphenotypic, Acute
6
Leukemia
6
Lymphoma, Non-Hodgkin
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, Large-Cell, Immunoblastic
3
Leukemia, Myeloid, Acute
3
Burkitt Lymphoma
3
Prostatic Neoplasms
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Multiple Myeloma
2
Lymphohistiocytosis, Hemophagocytic
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Graft vs Host Disease
2
Epstein-Barr Virus Infections
2
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pneumonia, Pneumocystis
1
Pneumonia
1
Pain
1
Neurotoxicity Syndromes
1
Neuroma, Acoustic
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Lymphoma, Large-Cell, Anaplastic
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Leukemia, Myeloid, Chronic-Phase
1
Interventions
Methylprednisolone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Pneumonia, Pneumocystis
×
Methylprednisolone
×
Clear all
NCT02944045
2020-10-06
PIC
Assistance Publique - Hôpitaux de Paris
Phase 3
Unknown
222 enrolled